Toseina Syrup is a codeine-based oral formulation commonly referenced in clinical settings for the management of persistent, dry cough. Codeine acts on receptors in the central nervous system to help suppress the cough reflex, providing relief in cases where coughing is non-productive and disruptive.

Manufactured to meet established pharmaceutical standards, Toseina Syrup is formulated for consistent quality and controlled potency. Due to its opioid component and potential for misuse or dependence, it is intended for regulated, medical, or research-focused contexts under appropriate supervision.

Key Features:

• Codeine-containing cough suppressant

• Targets persistent, non-productive cough

• Consistent formulation and quality control

• Intended for regulated clinical contexts